BioCentury
ARTICLE | Company News

Braintree, Ipsen deal

October 19, 2009 7:00 AM UTC

Ipsen received exclusive rights to market Braintree's BLI-800 in the EU, Commonwealth of Independent States, China, other Asian countries and parts of North Africa. The compound with an undisclosed m...